Source: International Congress 2016 – ILD pathogenesis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alaa Rashad Mahmoud (Qena, Egypt), Alaa Rashad Mahmoud, Asmaa Nafady. Tumor necrosis factor-alpha and CD4/CD8 ratio in patients with hypersensitivity pneumonitis. Eur Respir J 2016; 48: Suppl. 60, 3104

Member's Comments

No comment yet.

Related content which might interest you: Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-a2 gene Source: Eur Respir J 2002; 19: 912-918 Year: 2002 Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test? Source: International Congress 2015 – Screening strategies in TB Year: 2015 LATE-BREAKING ABSTRACT: Erythropoietin (EPO) inhibits the immunohistochemical expression of Tumor Necrosis Factor-a (TNF-a) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002 Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Source: Eur Respir J 2010; 35: 540-548 Year: 2010 High levels of vascular endothelial growth factor–C and D are associated with disease severity of hypersensitivity pneumonitis Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy Source: Eur Respir J 2001; 18: Suppl. 33, 233s Year: 2001 Pulmonary sarcoid-like granulomatosis during tumour necrosis factor-alpha inhibition: a scoping review Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 iNKT cells are inversely related to β-glucan in BALF and granuloma formation in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial Source: Eur Respir J 2014; 43: 295-298 Year: 2004 Evaluation of bronchoalveolar cells in pulmonary paracoccidioidomycosis Source: Eur Respir J 2003 Dec 01;22(6):895-899 Year: 2003 Interleukin 4 receptor, interleukin 17 and clinical presentation of chronic EAA Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Serum procalcitonin is useful in differentiating between drug-induced pneumonitis and bacterial pneumonia Source: International Congress 2014 – ILDs 5 Year: 2014 Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005 Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006 Levels of cytokines and chemokines in BAL fluid in patients with idiopathic interstitial pneumonitis and collagen vascular disease associated interstitial pneumonitis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Treatment response in hypersensitivity pneumonitis Source: International Congress 2016 – Orphan diseases II Year: 2016 Pulmonary lesions in patients with inflammatory bowel disease – the baseline and under anti-tumor necrosis factor therapy. Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017